Marcello Tiseo

1.4k total citations · 1 hit paper
9 papers, 918 citations indexed

About

Marcello Tiseo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Marcello Tiseo has authored 9 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Marcello Tiseo's work include Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (3 papers) and Cancer therapeutics and mechanisms (2 papers). Marcello Tiseo is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (3 papers) and Cancer therapeutics and mechanisms (2 papers). Marcello Tiseo collaborates with scholars based in Italy, Netherlands and Malaysia. Marcello Tiseo's co-authors include Alessandro Leonetti, Elisa Giovannetti, Roberta Minari, Sugandhi Sharma, Paola Perego, Lorenzo Tofani, Fausto Barbieri, Luigi Cavanna, Angelo Delmonte and Saverio Cinieri and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and Journal of Thoracic Oncology.

In The Last Decade

Marcello Tiseo

6 papers receiving 910 citations

Hit Papers

Resistance mechanisms to osimertinib in EGFR-mutated non-... 2019 2026 2021 2023 2019 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcello Tiseo Italy 3 659 511 425 214 73 9 918
Junko Hamamoto Japan 16 535 0.8× 446 0.9× 408 1.0× 153 0.7× 61 0.8× 27 808
Atsuko Ogino Japan 10 673 1.0× 527 1.0× 498 1.2× 176 0.8× 131 1.8× 18 917
Ken Uchibori Japan 15 614 0.9× 567 1.1× 360 0.8× 156 0.7× 64 0.9× 59 885
Ichiro Kawada Japan 18 673 1.0× 576 1.1× 516 1.2× 180 0.8× 97 1.3× 56 1.1k
Julia Rotow United States 14 654 1.0× 609 1.2× 582 1.4× 316 1.5× 85 1.2× 47 1.1k
Toshiki Takemoto Japan 15 616 0.9× 527 1.0× 381 0.9× 161 0.8× 83 1.1× 40 957
Jordi Bertrán-Alamillo Spain 14 514 0.8× 472 0.9× 437 1.0× 299 1.4× 82 1.1× 33 838
Anne McLeer‐Florin France 13 586 0.9× 420 0.8× 246 0.6× 260 1.2× 73 1.0× 17 895
G. Jeannin France 9 543 0.8× 465 0.9× 408 1.0× 165 0.8× 105 1.4× 21 840
Masaki Shimoji Japan 15 775 1.2× 676 1.3× 434 1.0× 204 1.0× 93 1.3× 38 1.1k

Countries citing papers authored by Marcello Tiseo

Since Specialization
Citations

This map shows the geographic impact of Marcello Tiseo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcello Tiseo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcello Tiseo more than expected).

Fields of papers citing papers by Marcello Tiseo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcello Tiseo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcello Tiseo. The network helps show where Marcello Tiseo may publish in the future.

Co-authorship network of co-authors of Marcello Tiseo

This figure shows the co-authorship network connecting the top 25 collaborators of Marcello Tiseo. A scholar is included among the top collaborators of Marcello Tiseo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcello Tiseo. Marcello Tiseo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Manini, M.A., Federica Pecci, Giulia Mazzaschi, et al.. (2025). 362P: LIPI score in advanced NSCLC treated with ICIs: Prognostic impact and blood immune-inflammatory correlations. Journal of Thoracic Oncology. 20(3). S215–S215.
2.
Pecci, Federica, et al.. (2025). 358P: Baseline circulating immunophenotype may predict irAEs onset in NSCLC patients treated with ICIs. Journal of Thoracic Oncology. 20(3). S213–S213. 1 indexed citations
3.
Genova, Carlo, Federico Cappuzzo, Giorgio Minotti, et al.. (2025). The effects of race on anti-PD-(L)1 monoclonal antibodies in non-small cell lung cancer: A systematic literature review and meta-analysis. Critical Reviews in Oncology/Hematology. 214. 104812–104812.
4.
Sposito, Marco, Ilaria Trestini, Daniela Tregnago, et al.. (2025). Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumab. Frontiers in Oncology. 15. 1635321–1635321.
5.
Minari, Roberta, Giulia Mazzaschi, Letizia Gnetti, et al.. (2024). MET alterations as resistance mechanisms of dabrafenib-trametinib in BRAF p.V600E mutated non-small cell lung cancer patient. Anti-Cancer Drugs. 35(8). 761–763. 1 indexed citations
6.
Balbi, Maurizio, Giulia Mazzaschi, Cristina Marrocchio, et al.. (2024). Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non–Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors. Journal of Thoracic Imaging. 40(1). 2 indexed citations
7.
Gelsomino, Francesco, Marcello Tiseo, Fausto Barbieri, et al.. (2020). Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL). British Journal of Cancer. 123(1). 26–32. 19 indexed citations
8.
Leonetti, Alessandro, Sugandhi Sharma, Roberta Minari, et al.. (2019). Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer. British Journal of Cancer. 121(9). 725–737. 893 indexed citations breakdown →
9.
Gelsomino, Francesco, Marcello Tiseo, Fausto Barbieri, et al.. (2018). Phase II study of NAB-paclitaxel in sensitive and refractory relapsed SCLC (NABSTER TRIAL). Annals of Oncology. 29. viii599–viii599. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026